1. Home
  2. MDXG vs REAX Comparison

MDXG vs REAX Comparison

Compare MDXG & REAX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MDXG
  • REAX
  • Stock Information
  • Founded
  • MDXG 2006
  • REAX 2018
  • Country
  • MDXG United States
  • REAX United States
  • Employees
  • MDXG N/A
  • REAX N/A
  • Industry
  • MDXG Biotechnology: Pharmaceutical Preparations
  • REAX
  • Sector
  • MDXG Health Care
  • REAX
  • Exchange
  • MDXG Nasdaq
  • REAX Nasdaq
  • Market Cap
  • MDXG 877.4M
  • REAX 814.5M
  • IPO Year
  • MDXG N/A
  • REAX N/A
  • Fundamental
  • Price
  • MDXG $6.67
  • REAX $4.08
  • Analyst Decision
  • MDXG Strong Buy
  • REAX Strong Buy
  • Analyst Count
  • MDXG 2
  • REAX 3
  • Target Price
  • MDXG $12.50
  • REAX $6.33
  • AVG Volume (30 Days)
  • MDXG 771.8K
  • REAX 1.1M
  • Earning Date
  • MDXG 07-30-2025
  • REAX 08-07-2025
  • Dividend Yield
  • MDXG N/A
  • REAX N/A
  • EPS Growth
  • MDXG N/A
  • REAX N/A
  • EPS
  • MDXG 0.27
  • REAX N/A
  • Revenue
  • MDXG $352,375,000.00
  • REAX $1,417,877,000.00
  • Revenue This Year
  • MDXG $9.55
  • REAX $43.20
  • Revenue Next Year
  • MDXG $11.43
  • REAX $15.30
  • P/E Ratio
  • MDXG $25.11
  • REAX N/A
  • Revenue Growth
  • MDXG 5.34
  • REAX 81.30
  • 52 Week Low
  • MDXG $5.47
  • REAX $3.80
  • 52 Week High
  • MDXG $10.14
  • REAX $6.75
  • Technical
  • Relative Strength Index (RSI)
  • MDXG 57.60
  • REAX 43.46
  • Support Level
  • MDXG $5.86
  • REAX $4.07
  • Resistance Level
  • MDXG $7.05
  • REAX $4.34
  • Average True Range (ATR)
  • MDXG 0.24
  • REAX 0.18
  • MACD
  • MDXG 0.11
  • REAX -0.01
  • Stochastic Oscillator
  • MDXG 69.20
  • REAX 21.17

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are primarily targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

About REAX The Real Brokerage Inc.

The Real Brokerage Inc is a technology-powered real estate brokerage firm located in the United States and Canada. It has developed a proprietary transaction management and brokerage operations software called reZEN, which powers nearly all of its brokerage operations, enabling efficiency, automation, and flexibility by incorporating end-to-end transaction management, automated compliance and brokerage oversight, integrated payments and financial services, Leo CoPilot, and open API for customization. In addition, the company also offers mortgage brokering and title services. The company's operating segments are North American Brokerage, which derives key revenue, One Real Title, One Real Mortgage, and Real Wallet. Geographically, it derives key revenue from the United States.

Share on Social Networks: